Biomarin Pharma Earnings, Revenue beat in Q1 By Investing.com
Biomarin Pharma (NASDAQ:BMRN) reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations. Biomarin Pharma announced earnings per share of $0.09 on revenue of $486M. Analysts polled by Investing.com anticipated EPS of $-0.0923 on revenue of $446.78M. Biomarin Pharma shares are down 8.5% from the beginning of the year and are trading at $80.24 , down-from-52-week-high.They are under-performing the Nasdaq which is up 9.27% from the start of the year. Biomarin Pharma follows other major Healthcare sector earnings this month Biomarin Pharma's report follows an earnings beat...
Continue reading